2010 to 2021 Saw Rise in Hypertensive Disorders of Pregnancy
By Lori Solomon HealthDay Reporter
MONDAY, June 10, 2024 -- There was an increase in hypertensive disorders of pregnancy and most associated risk factors between 2010 and 2021 overall in the entire U.S. pregnant population, according to a research letter published online June 10 in the Journal of the American Medical Association.
Mariam K. Ayyash, M.D., from the Columbia University Irving Medical Center in New York City, and colleagues evaluated trends in preeclampsia risk factors in the United States between 2010 and 2021. The analysis included 32.75 million births identified from the National Vital Statistics System database.
The researchers found that the rate of chronic hypertension increased from 1.2 to 2.7 percent (relative increase, 125 percent) and pregestational diabetes increased from 0.7 to 1.1 percent (relative increase, 57.1 percent). There was a decrease observed in multifetal gestation from 1.7 to 1.2 percent (relative decrease, 29.4 percent). As for moderate risk factors, the rate of obesity increased from 22.5 to 30.5 percent (relative increase, 35.6 percent), advanced maternal age increased from 14.7 to 20.1 percent (relative increase, 36.7 percent), in vitro fertilization increased from 0.5 to 1.5 percent (relative increase, 200 percent), and the interpregnancy interval increased from 5.6 to 6.3 percent (relative increase, 12.5 percent), although nulliparity decreased from 42.8 to 40.0 percent (relative decrease, 6.5 percent). There was an increase seen in hypertensive disorders of pregnancy from 4.4 to 9.4 percent (relative increase, 113.6 percent).
"Although the absolute changes in risk factors were small, such differences can be important on a population-wide scale," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-06-11 16:47
Read more
- 1990 to 2019 Saw Increase in Life Expectancy in Seniors With T1DM
- About One-Third of Mental Health Facilities Offer Meds for Opioid Addiction
- Reported Symptoms Most Sensitive Indicator of Concussion
- FDA Approves Rytelo (imetelstat) for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia
- First Patient Enrolled in Global Phase 3 Clinical Program for Elamipretide in Patients with Dry Age-Related Macular Degeneration
- Recommendations Issued for Advanced Imaging for Pediatric Patients in ED
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- penginapan di alahan panjang
- nutrition faktory
- doksisiklin
- waist adalah
- kolonoskopi adalah
- obat glimepiride
- antiemetik adalah
- efek samping metformin
- sudut 45 derajat
- plasebo adalah
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions
- qulipta side effects anxiety
- repotrectinib side effects
- ibrance para que sirve
- foods to avoid while taking enbrel
- 反応 速度 鍛える
- baby shampoo eczema
- cdk inhibitor breast cancer
- xulane package insert
- loryna side effects
- keytruda pi
- estarylla vs sprintec
- pros and cons of junel birth control
- tissue plasminogen activator
- jolessa
- ワセリン ベビー パウダー
- tintes para piel morena
- parp 阻害 薬
- デスモイド
- erau ernie
- vasoplex side effects
- rutina de hombros
- merk pre workout
- 湾曲ペニス
- best work out shoes
- ウィニペグ大学
- transparent labs creatine hmb
- nutrition faktory
- メトホルミン 効果発現
- お 風呂 おもちゃ 赤ちゃん
- メトホルミン 副作用